Navigation Links
BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year
Date:11/2/2011

:Income from continuing operations

$

1.39

$

1.279.4(Loss) Income from discontinued operations

$

(0.01)

$

0.45NM Net income (1)

$

1.38

$

1.71(19.3)Diluted:Income from continuing operations

$

1.36

$

1.249.7(Loss) Income from discontinued operations

$

(0.01)

$

0.44NM Net income (1)

$

1.36

$

1.68(19.0)AVERAGE SHARES OUTSTANDINGBasic216,726231,396Diluted220,859236,316NM - Not Meaningful(1) Total per share amounts may not add due to rounding. Page 1BECTON DICKINSON AND COMPANY CONSOLIDATED INCOME STATEMENTS(Unaudited; Amounts in thousands, except per share data)Twelve Months Ended September 30,20112010% ChangeREVENUES

$

7,828,904

$

7,372,3336.2Cost of products sold3,737,3523,543,1835.5Selling and administrative 1,851,7741,721,3567.6Research and development476,496430,99710.6TOTAL OPERATING COSTSAND EXPENSES6,065,6225,695,5366.5OPERATING INCOME1,763,2821,676,7975.2Interest income43,20935,12923.0Interest expense(84,019)(51,263)63.9Other (expense) income, net(6,209)497NM INCOME FROM CONTINUING OPERATIONS BEFOREINCOME TAXES1,716,2631,661,1603.3Income tax provision451,411484,820(6.9)INCOME FROM CONTINUING OPERATIONS1,264,8521,176,3407.5INCOME FROM DISCONTINUED OPERATIONS   NET OF INCOME TAX PROVISION OF$792 AND $40,703, RESPECTIVELY6,142141,270NM NET INCOME

$

1,270,994

$

1,317,610(3.5)EARNINGS PER SHAREBasic:Income from continuing operations

$

5.72

$

5.0213.9Income from discontinued operations

$

0.03

$

0.60(95.0)Net income

$

5.75

$

5.622.3Diluted:Income from continuing operations

$

5.59

$

4.9014.1Income from discontinued operations

$

0.03

$

0.59(94.9)Net income

$

5.62


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results
2. Genomic Health Announces Third Quarter 2011 Financial Results and Business Progress
3. Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe
4. Perrigo Announces Launch of Generic Version of Elestat®
5. Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. CRC Health Group Announces Acquisition of North Carolinas Mountain Health Solutions
7. Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
8. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
9. Medela Announces Virtual Breast Milk Collection Campaign in Honor of Prematurity Awareness Month
10. Rigel Announces Third Quarter 2011 Financial Results
11. Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PITTSBURGH , July 30, 2014   ... Markets Groups Inc.: OTC Pink: UPZS), a Delaware ... a distribution agreement with Larasan Pharmaceutical Corporation ("Larasan"), a ... products.  According to the agreement, US-based Larasan will ... gourmet 6" frozen pizza through Larasan,s vast distribution ...
(Date:7/30/2014)... TARRYTOWN, N.Y. and PARIS ... REGN ) and Sanofi (EURONEXT: SAN and ... new Phase 3 ODYSSEY trials of alirocumab in people ... greater percent reduction from baseline in low-density lipoprotein cholesterol ... comparator.  Alirocumab is an investigational monoclonal antibody targeting PCSK9 ...
(Date:7/30/2014)... -- Packaging Coordinators, Inc. (PCI) is pleased to announce it ... Services Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... United Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug ... form manufacturing, as well as Clinical Packaging, Labeling, and ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
... imaging,(BSGI) is effective in the detection of cancers not ... study presented today at the annual meeting of,the Radiological ... "BSGI can identify the most difficult ... F. Brem, M.D., professor of,radiology and director of the ...
... Horizon Therapeutics, Inc., a,privately held biopharmaceutical ... 3 trials evaluating its lead investigational ... HZT-501, a novel, proprietary fixed-dose,combination product ... significant reduction in the incidence of ...
Cached Medicine Technology:New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4
(Date:7/30/2014)... 30, 2014 Hamilton Facial Plastic ... its new Carmel office on July 30th. After months ... be moving to the state-of-the-art suite, located only steps ... space will allow for one-on-one patient comfort, shorter wait ... , Dr. Hamilton’s new office-suite will continue to ...
(Date:7/30/2014)... (July 30, 2014) The phrase "we caught it early" ... in the midst of a cancer diagnosis. Combating cancer ... to a certain part of the body, gives patients ... breast, skin, colon, prostate and other forms of cancer ... health care providers recommend cancer screenings as a precautionary ...
(Date:7/30/2014)... 2014. A new network of 25 regional stroke centers ... (NIH StrokeNet) is working to change the way ... advances of the last two decades, stroke remains a ... or disability for 795,000 Americans. The numbers are expected ... , To accelerate the pace of progress, NIH ...
(Date:7/30/2014)... July 30, 2014 The Technology Association ... Alliance of TAG (B&TA), today issued its final call ... Awards. , Interested companies have until August 29th 2014 ... Semi-Finalists will be selected by the Excalibur Judging Committee. ... meet with the judges for interviewing process. , ...
(Date:7/30/2014)... 2014 Over 630 doctors worldwide are ... the revolutionary minimally invasive treatment for gum recession. Santa ... of his peers to be the “father of microsurgery” ... recent Chao Pinhole Surgical Technique® training course at the ... the recipient of the American Academy of Periodontics (AAP) ...
Breaking Medicine News(10 mins):Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:Periodontist Dr. Dennis Shanelec Comments On The Chao Pinhole Surgical Technique® Training Course 2
... the form of a throat spray, researchers say , TUESDAY, ... may someday be able to avoid a tonsillectomy and get ... potentially dangerous snoring, new research suggests. , In a report ... Respiratory and Critical Care Medicine , researchers say that they,ve ...
... ... Human Services uses Percussion Community Marketing Solution to implement President Obama’s Open Government ... ... Health and Human Services is using Percussion Software’s Web Content Management System and ...
... , , SAN DIEGO , Feb. 10 ... dreams are attainable.  Back in the third quarter of 2006, 62% of ... achieving their personal dreams.  Now 55% of Americans feel this way.  On ... chance or it is impossible for them to achieve their dreams – ...
... Lou ... President of Product Marketing. , ... Charlottesville, VA (PRWEB) Feb. 29, 2010 -- Silverchair Learning Systems (SLS), the leading online education ... Robinson has joined the company as its Director of Home Health Clinical Content, and Vince ...
... ... has received a two-year grant from Merck & Co., Inc. to launch the Journey ... the EDGE Program is to improve diabetes education by enhancing the role of state ... Diabetes Conversation Maps. , ...
... , ... network announces a limited offering of free listings on its popular values-based therapist directory. ... on the directory is limited and the offering expires February 19th, 2010. , ... Olympia, WA (PRWEB) February 10, 2010 -- ...
Cached Medicine News:Health News:Web Content Management Enables Government Transparency, Participation, and Collaboration Online 2Health News:Web Content Management Enables Government Transparency, Participation, and Collaboration Online 3Health News:Web Content Management Enables Government Transparency, Participation, and Collaboration Online 4Health News:Luth Research's IndicatorEDG(TM) Study Finds Americans' Hopes of Achieving Their Dreams Are Fading 2Health News:Luth Research's IndicatorEDG(TM) Study Finds Americans' Hopes of Achieving Their Dreams Are Fading 3Health News:Luth Research's IndicatorEDG(TM) Study Finds Americans' Hopes of Achieving Their Dreams Are Fading 4Health News:Silverchair Learning Systems Enhances Product Expertise with New Hires 2Health News:NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education 2Health News:NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education 3Health News:Theravive.com Offers A Free Therapist Listing For Credentialed Counselors and Psychologists 2Health News:Theravive.com Offers A Free Therapist Listing For Credentialed Counselors and Psychologists 3
... Focus multichannel pipettes speed ... reagents into microplates, with ... l volumes. The improved ... Focus multichannels, combined with ...
... rows, and microplatesthat is the area of ... becoming an ever-increasing force. Ergonomics (reduced weight ... reason that the Multichannel Research model was ... provides effective, precise, and rapid processing of ...
... Hall, the aortic and mitral valves are distinctly ... the disc opens to 75 to maximize forward ... to minimize regurgitation. Designed to rotate within its ... the leading edge of the disc parallel to ...
Inquire...
Medicine Products: